Grant Street Asset Management’s Edwards Lifesciences EW Stock Holding History

Grant Street Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,555	Closed	-$201K	–	55
2021 Q4	$201K	Buy	+1,555	New	+$181K	0.11%	52
2021 Q2	–	Sell	-1,680	Closed	-$141K	–	90
2021 Q1	$141K	Hold	1,680	–	–	0.08%	60
2020 Q4	$153K	Buy	+1,680	New	+$139K	0.08%	36

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Grant Street Asset Management's EW Position: Q1 2022 in Review

Grant Street Asset Management sold out of Edwards Lifesciences (EW) in Q1 2022, closing a stake of 1,555 shares — an estimated $201K sold.

Grant Street Asset Management first reported a position in EW in Q4 2020 and held it in 3 quarters. The position peaked at $201K in Q4 2021. 1,312 funds tracked by Wall St. Rank hold EW as of Q1 2022.

Grant Street Asset Management reported no remaining Edwards Lifesciences position as of Q1 2022 after selling out during the quarter.
Grant Street Asset Management sold 1,555 Edwards Lifesciences shares in Q1 2022, an estimated $201K.
Grant Street Asset Management first reported a position in Edwards Lifesciences in Q4 2020 and held it in 3 quarters.
Grant Street Asset Management's Edwards Lifesciences position peaked at $201K in Q4 2021.
1,312 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2022.

Based on Grant Street Asset Management's 13F filing for Q1 2022, filed 10 May 2022.